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Background Quitting tobacco or alcohol use has been reported to reduce the
head and neck cancer risk in previous studies. However, it is
unclear how many years must pass following cessation of these
habits before the risk is reduced, and whether the risk ultimately
declines to the level of never smokers or never drinkers.
Methods We pooled individual-level data from case–control studies in the
International Head and Neck Cancer Epidemiology Consortium.
Data were available from 13 studies on drinking cessation (9167
cases and 12 593 controls), and from 17 studies on smoking cessa-
tion (12 040 cases and 16 884 controls). We estimated the effect of
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quitting smoking and drinking on the risk of head and neck cancer
and its subsites, by calculating odds ratios (ORs) using logistic
regression models.
Results Quitting tobacco smoking for 1–4 years resulted in a head and neck
cancer risk reduction [OR 0.70, confidence interval (CI) 0.61–0.81
compared with current smoking], with the risk reduction due to
smoking cessation after 520 years (OR 0.23, CI 0.18–0.31), reach-
ing the level of never smokers. For alcohol use, a beneficial effect
on the risk of head and neck cancer was only observed after 520
years of quitting (OR 0.60, CI 0.40–0.89 compared with current
drinking), reaching the level of never drinkers.
Conclusions Our results support that cessation of tobacco smoking and cessation
of alcohol drinking protect against the development of head and
neck cancer.
Keywords Epidemiology, head and neck cancer, cessation, alcohol drinking,
tobacco smoking
Introduction
Worldwide, more than half a million cases of head and
neck cancer (oral cavity, oropharynx, hypopharynx
and larynx) are estimated to occur each year, making
it the seventh most common cancer in the world.1
By 2020, growth and ageing of the population will
lead to a doubling of these figures to41 million new
cases and over half a million deaths every year. Head
and neck cancer is the most common cancer among
men aged <55 years worldwide.1 Strong time trends
with increasing incidence and mortality rates have
been observed in Central and Eastern Europe.2–4 In
Western countries, the main risk factors for head and
neck cancer are alcohol drinking and tobacco smoking,
which together account for 75% of the disease.5
Quitting tobacco smoking has been reported to
reduce the risk of head and neck cancer in previous
studies. At least five cohort studies and 40 case–
control studies suggested a reduction of head and
neck cancer risk after the cessation of tobacco smok-
ing to the order of 16–85%.6–14 The risk of head and
neck cancer was shown to decrease with time since
stopping smoking, but only eight of these studies
evaluated quitting smoking for 520 years. Of these
eight studies, three studies of laryngeal cancer
reported that individuals who quit for 520 years
still have elevated risks of laryngeal cancer compared
with never smokers.15–17 The five other studies
on oral and pharyngeal cancer risk reported that the
risk was similar to never smokers after quitting for
520 years.10,18–21
In contrast to the numerous studies on smoking
cessation, there have been fewer studies of head
and neck cancer and quitting alcohol drinking. The
results of seven case–control studies were inconsis-
tent, with some showing increased risks or
unchanged risks,7–9,16,21–23 and others showing
decreased risks after quitting alcohol drinking com-
pared with current drinkers. A risk reduction of oral
cavity and pharyngeal cancers after cessation of drink-
ing was observed in two studies,7,9 but no association
was observed in two other studies.8,21 A decline in risk
of laryngeal cancer was found after stopping drinking
compared with current drinkers in an Uruguayan
investigation23 and in the multicentre case–control
study in Italy and Switzerland.16 On the other hand,
in a study from the same area, Franceschi et al.22
reported a higher risk of oral cavity and pharyngeal
cancer 7–10 years after cessation of drinking compared
with current drinkers, which did not decrease even
after more years of quitting.
To evaluate the effect of cessation of alcohol drink-
ing and tobacco smoking, we pooled data from
18 case–control studies from around the world
within the International Head and Neck Cancer
Epidemiology (INHANCE) consortium. Our aim was
to estimate the number of years of quitting required
to observe a reduced risk and whether the risk
declines to the level of never smokers and never drin-
kers. In addition, we were interested in whether the
risk reversal differs by head and neck cancer subsite,
and by frequency of tobacco or alcohol use before
quitting. A precise estimation of the beneficial effect
of cessation of alcohol drinking and tobacco smoking
has important public health implications since quit-
ting these habits can be encouraged by public health
intervention.
Research design and methods
A detailed description of the INHANCE consortium
with characteristics of the individual studies
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and the pooling methods for the first data version 1.0
including 16 case–control studies was provided pre-
viously.24 Two new studies were added (Boston and
Rome) for data version 1.1. The current analysis
included the 18 studies with 12 282 head and neck
cancer case subjects and 17 189 control subjects.
Case and control subjects with missing data on age,
sex or race/ethnicity, and case subjects with missing
information on the site of origin of their cancer were
excluded (62 case subjects and 103 control subjects).
Data were available in 13 case–control studies on the
cessation of alcohol (wine, beer, liquor or aperitif)
drinking (9167 cases and 12 593 controls), and in 17
case–control studies on the cessation of tobacco (cig-
arette, cigar or pipe) smoking (12 040 cases and
16 884 controls).
Most of the INHANCE data came from hospital-
based case–control studies (Milan, Aviano, France,
Italy, Switzerland, Central Europe, Rome, New York,
Iowa, North Carolina, Tampa, Houston, Latin
America, international multicentre studies), in which
the control subjects were frequency matched to the
case subjects on age, sex and additional factors
(such as study centre, hospital and race/ethnicity).
The other studies were population-based case–control
studies (Seattle, Los Angeles, Puerto Rico, Boston).
The Los Angeles study individually matched the
control subjects to case subjects on age decade,
gender and neighbourhood, though in this analysis
the matching was broken. Face-to-face interviews
were conducted in all studies except for the Iowa
study, in which subjects completed self-administered
questionnaires.
Written informed consent was obtained from all
study subjects, and the investigations were approved
by the institutional review board at each study
centre. Questionnaires were collected from all the
individual studies to assess the comparability of the
collected data and of the wording of interview ques-
tions among the studies. Data from individual studies
were received at the International Agency for
Research on Cancer (IARC) with personal identifiers
removed. Each data item was checked for inconsistent
or missing values. Queries were sent to the investiga-
tors to resolve inconsistencies.
Case subjects were included in this study if their
tumour had been classified by the original study as
an invasive tumour of the oral cavity, oropharynx,
hypopharynx, oral cavity or pharynx not otherwise
specified (NOS), larynx or head and neck cancer unspe-
cified according to the International Classification
of Diseases—Oncology, Version 2 (ICD-O-2) or the
International Classification of Diseases, 9th or 10th
Revision (ICD 9 or ICD 10, respectively).25–27 Subjects
with salivary gland cancers (ICD-O-2 topography codes
C07–C08) and external lip cancers (ICD-O-2 topography
codes C00.0–C00.2) were excluded from our analysis
because the etiologic pattern of these cancers differs
from that of other head and neck cancers.28 In our
data, there were 3390 case subjects with oral cavity
cancer, 3875 with pharyngeal cancer (oropharyngeal
or hypopharyngeal), 969 with oral cavity or pharynx
not otherwise specified, 2821 with laryngeal cancer
and 306 with unspecified head and neck cancers.
Some studies (in France, North Carolina, Tampa and
Houston) restricted eligibility to case subjects with
squamous cell carcinomas (SCCs). For other studies
that provided the ICD-O-2 histological coding for each
tumour, we used the codes to identify case subjects with
SCC. Of the 7709 head and neck cancer case subjects
for whom histological information was available, 7475
(97.0%) had SCC.
The questions about tobacco and alcohol use on
study questionnaires were conceptually similar
across studies, but because the exact wording dif-
fered, they were examined carefully for comparability
before variables were created for the data analyses.
In the alcohol section of the study questionnaires,
subjects were asked if they had been alcohol drinkers;
for those who responded that they were, variables
on frequency, duration and cumulative consumption
of drinking overall, and by types of alcohol beverages
(beer, wine and hard liquor) were calculated. Age at
stopping alcohol drinking was available from 13 stu-
dies. Former drinkers were defined as subjects
who had quit drinking the following alcoholic bev-
erages: wine, beer, liquor and aperitifs. For quitting
alcohol drinking, we classified subjects who had
stopped drinking for 41 year as former drinkers.
The number of years that former drinkers had quit
drinking was determined from age at reference date
(interview or diagnosis date) and age at which he/she
had stopped drinking.
Each study subject was asked whether he/she had
ever been a cigarette, cigar or pipe smoker. Variables
on the frequency, duration and pack-years (PYs) of
tobacco smoking were available in all studies.
Age at stopping tobacco smoking was available from
17 studies. We classified former smokers as indivi-
duals who had quit smoking these tobacco products:
cigarette, cigar and pipe. For quitting tobacco smok-
ing, we defined subjects who had stopped smoking
for41 year as former smokers. Time since cessation
of tobacco smoking was calculated from age at refer-
ence date (interview or diagnosis date) and age at
which the individual stopped smoking any type of
tobacco (cigarette, cigar, pipe).
Information about snuff use and chewing habits
was collected by the Puerto Rico study, the interna-
tional multicentre studies and all studies in North
America. Snuff use and chewing are not common
behaviours in Europe or Latin America, except in spe-
cific populations (e.g. Norway and Sweden), which
were not included in the pooled dataset. For the
Indian component of the international multicentre
study, information on betel quid and areca nut chew-
ing was collected. Frequency and duration variables
for chewing and snuff use habits were pooled across
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relevant studies. For this study, never users of tobacco
were defined as individuals who had not used cigar-
ettes, cigars, pipes, snuff or chewing products during
their lifetimes.
Other potential confounders considered included
involuntary smoking and family history of head and
neck cancer. Data on involuntary smoking exposure at
home and at work (never/ever), which were available
in six studies, were pooled (Central Europe, Tampa,
Los Angeles, Houston, Puerto Rico and Latin America
studies). A variable on the number of first-degree
relatives who had head and neck cancer was also
pooled across the 12 studies that had assessed this
information (Milan, Aviano, Italy multicentre,
Switzerland, Central Europe, North Carolina, Tampa,
Los Angeles, Houston, Puerto Rico, Latin America and
international multicentre studies).
Statistical methods
We estimated the effect of quitting tobacco smoking
or alcohol drinking on the risk of head and neck
cancer, by calculating odds ratios (ORs) and 95%
confidence intervals (CIs) using unconditional logistic
regression models for each case–control study.
The adjusted models included sex, age (categories
shown in Table 1), education level (categories
shown), race/ethnicity (categories shown) and
study centre (categories shown), tobacco PYs (as a
continuous variable) and frequency of alcohol drink-
ing (as a continuous variable). In addition, we
adjusted for body mass using the body mass
index (BMI) at age 30 years (<18.5 kg/m2, 18.5
to <25 kg/m2, 25 to <30 kg/m2, 530 kg/m2), status
of involuntary tobacco smoking (never, ever) or
status of family history of head and neck cancer
(yes/no) in selected models. To calculate summary
estimates of associations, the study-specific estimates
were included in a two-stage random-effects logistic
regression model using the maximum likelihood
estimator, which allows for unexplained sources
of heterogeneity among studies. Pooled ORs were
also estimated with a fixed-effects logistic regression
model that adjusted for age, sex, education level,
race/ethnicity and study centre. All analyses were
conducted using SAS statistical software 9.1 (SAS
Institute Inc, Cary, NC).
For subjects with a missing education level [694
case subjects (7.6%) and 464 control subjects (3.7%)
for analyses of cessation of alcohol drinking, 980 case
subjects (8.1%) and 781 control subjects (4.6%) for
analyses of cessation of tobacco smoking], we applied
a multiple imputation with a logistic regression
method for a single missing data item. We assumed
that the education data were missing at random;
that is, whether or not education level was missing
Table 1 Selected characteristics of head and neck cancer case and control subjects
Analysis of alcohol drinking Analysis of tobacco smoking
Cases Controls Cases Controls
n % n % n % n %
Total 9167 12 593 12 040 16 884
Study
Europe
Milan, Italy – – 416 3.5 1531 9.1
Aviano, Italy – – 482 4.0 855 5.1
France 323 3.5 234 1.9 323 2.7 234 1.4
Italy 1058 11.5 2579 20.5 1058 8.8 2579 15.3
Switzerland 516 5.6 883 7.0 516 4.3 883 5.2
Central Europe – – 762 6.3 907 5.4
Rome, Italy – – 275 2.3 294 1.7
North America
New York city, NY – – 1118 9.3 906 5.4
Seattle, WA 407 4.4 607 4.8 407 3.4 607 3.6
Iowa, IA 546 6.0 759 6.0 546 4.5 759 4.5
North Carolina, NC 180 2.0 202 1.6 – –
Tampa, FL 207 2.3 897 7.1 207 1.7 897 5.3
Los Angeles, CA 417 4.5 1005 8.0 417 3.5 1005 6.0
Houston, TX 829 9.0 865 6.9 829 6.9 865 5.1
Boston, MA 584 6.4 659 5.2 584 4.9 659 3.9
(continued)
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Table 1 Continued
Analysis of alcohol drinking Analysis of tobacco smoking
Cases Controls Cases Controls
n % n % n % n %
Latin/Central America
Puerto Rico 350 3.8 521 4.1 350 2.9 521 3.1
Latin America 2191 23.9 1706 13.5 2191 18.2 1706 10.1
International
multicentre 1559 17.0 1676 13.3 1559 12.9 1676 9.9
Age (years)
<40 376 4.1 816 6.5 472 3.9 1114 6.6
40–44 545 5.9 964 7.7 690 5.7 1267 7.5
45–49 1050 11.5 1439 11.4 1326 11.0 1874 11.1
50–54 1409 15.4 1999 15.9 1850 15.4 2606 15.4
55–59 1724 18.8 2154 17.1 2247 18.7 2916 17.3
60–64 1471 16.0 1931 15.3 2053 17.1 2621 15.5
65–69 1197 13.1 1551 12.3 1643 13.6 2145 12.7
70–74 821 9.0 1115 8.9 1070 8.9 1533 9.1
575 574 6.3 624 5.0 689 5.7 808 4.8
Race/Ethnicitya
White 5661 61.8 9175 72.9 8488 70.5 13 418 79.5
Black 391 4.3 513 4.1 432 3.6 560 3.3
Hispanic 158 1.7 349 2.8 164 1.4 349 2.1
Asian/Pacific Islander 625 6.8 666 5.3 629 5.2 667 4.0
Latin American 2191 23.9 1706 13.5 2191 18.2 1706 10.1
Others 141 1.5 184 1.5 136 1.1 184 1.1
P-value for chi-square
heterogeneity test
<0.001 <0.001
Sex
Female 2023 22.1 3759 29.8 2544 21.1 4817 28.5
Male 7144 77.9 8834 70.2 9496 78.9 12 067 71.5
Education
No formal education 437 4.8 285 2.3 448 3.7 307 1.8
Less than junior high school 3642 39.7 4478 35.6 4561 37.9 6417 38.0
Some high school 1197 13.1 1420 11.3 1563 13.0 1891 11.2
High school graduate 1153 12.6 1657 13.2 1739 14.4 2141 12.7
Vocational school, some
college
1077 11.7 2020 16.0 1355 11.3 2511 14.9
College graduate/
postgraduate
967 10.5 2269 18.0 1394 11.6 2836 16.8
Missing 694 7.6 464 3.7 980 8.1 781 4.6
P-value for chi-square
heterogeneity test
<0.001 <0.001
aInformation on ethnicity were not collected in the Central Europe, France, Rome and Latin America studies. In the Central
Europe, France and Rome studies, all subjects were classified as non-Hispanic White, since the large majority of these populations
are expected to be White. In the Latin American study, we categorized subjects as ‘Latin American’. We adjusted for study centre in
all logistic regression models as a proxy variable for race/ethnicity since each centre has an expected predominant ethnic group
distribution.
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did not depend on the unobserved or missing values
of education.29 We used a logistic regression model to
predict education level for each of the geographic
regions separately using age, sex, race/ethnicity,
study centre and case–control status as the covari-
ates.30 The logistic regression results to assess sum-
mary estimates for cessation of tobacco smoking and
alcohol drinking for five imputations were combined
with the PROC MIANALYZE procedure.31
We tested for heterogeneity among the study ORs by
using a likelihood ratio test comparing a model includ-
ing the product terms between each study (other than
the reference study) with the variable of interest and a
model without the product terms. We report the
random-effects estimates, because heterogeneity was
detected in almost all models. We confirmed that the
magnitude of the effect from the two-stage random-
effects model and from the fixed-effect logistic regres-
sion model were comparable with each other. We also
conducted influence analysis, in which each study was
excluded one at a time to assure that the association
and the magnitude of the overall summary estimate
was not dependent on any one study.
Analyses were stratified by cancer site (oral cavity,
oro-/hypopharynx and larynx), age (<44, 45–54,
55–64, 565 years), sex, education level (categories
shown in Table 1), race/ethnicity (categories shown),
geographic region (Europe, North America, South/
Central America, others), source of control subjects
(hospital-based vs population-based), study year
(before 2000, 2000 or later) and study sample size
(500 cases or less, more than 500 cases). In addition,
we stratified the results for quitting tobacco smoking by
frequency of smoking (categories shown in Table 3),
duration of smoking and status of alcohol drinking.
For cessation of alcohol drinking, we additionally stra-
tified the results by frequency of drinking (categories
shown), duration of drinking and status of tobacco
smoking. All statistical tests were two-sided.
Results
The distributions of case and control subjects for
selected characteristics are shown in Table 1.
Subjects with head and neck cancer were slightly
less educated, compared with control subjects.
Overall, 26.0% of case subjects and 20.1% of control
subjects were former alcohol drinkers, and 19.6% of
case subjects and 29.1% of control subjects were
former tobacco smokers.
Cessation of alcohol drinking
Quitting alcohol drinking was associated with a 40%
decreased risk of head and neck cancer (OR 0.60;
95% CI 0.40–0.89) after 520 years of cessation com-
pared with current drinkers (Table 2). The beneficial
effect of quitting alcohol drinking520 years compared
with current drinkers was estimated in eight studies, of
which six showed an association, whereas three
studies reported no association between drinking
cessation and the reversal of head and neck cancer
risk (Figure 1). The risk reversal of head and neck
cancer after quitting alcohol drinking for 520 years
was observed across all subsites of head and neck
cancer, but an inverse trend with the years of quitting
alcohol was apparent only for oral cavity cancer
(Table 2).
Among subjects who drank one or more drinks per
day, the head and neck cancer ORs for quitting drink-
ing were 0.88 (95% CI 0.64–1.23) for 1–4 years, 0.81
(95% CI 0.54–1.22) for quitting drinking 5–9 years,
0.82 (95% CI 0.61–1.10) for quitting drinking 10–19
years, 0.44 (95% CI 0.25–0.77) for quitting drinking
520 years and 0.55 (95% CI 0.36–0.84) for never
drinking compared with current drinking (data not
shown). When results were stratified by alcohol drink-
ing frequency, we observed an increased risk among
low frequency drinkers who quit drinking 1–4 years
ago for pharyngeal and laryngeal cancer (Table 3).
The ORs after quitting drinking 520 years appeared
to decrease with increasing frequency of alcohol drink-
ing for head and neck cancer overall (<1 drink/day:
OR 1.00, 95% CI 0.72–1.39; 1–2 drinks/day: OR 0.76,
95% CI 0.52–1.12; 53 drinks/day: OR 0.54, 95% CI
0.31–0.94; data not shown), as well as for oral cavity
cancer and laryngeal cancer. The risk of pharyngeal
cancer after quitting drinking 520 years decreased
only slightly with increasing frequency. Such trends
were not observed with increasing categories for dura-
tion of alcohol drinking (results not shown).
0.60
OR
Italy                     49/96
Seattle              126/163
Iowa                    26/44
North Carolina      7/11
Tampa                  8/43
Los Angeles        24/61
Houston                5/52
Boston                34/51
Puerto Rico        27/50
Latin America  229/155
International        16/36
Combined OR 592/763
By study
1.14
1.63
0.42
0.12
0.18
1.02
0.55
0.64
0.75
0.75
0.25
(0.40–0.89)
(0.76–1.71)
(0.79–3.37)
(0.24–0.74)
(0.03–0.47)
(0.06–0.53)
(0.59–1.76)
(0.35–0.87)
(0.39–1.06)
(0.41–1.39)
(0.59–0.96)
(0.13–0.49)
Cases/Controls  95% CI
0.01 0.10 1.00 10.00
OR
Figure 1 Cessation of drinking 520 years and head and
neck cancer risk compared with current drinking
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An inverse relationship between quitting drinking
and the risk of oral cavity cancer and laryngeal
cancer was detected among current smokers, but not
among former or never smokers (Table 4). For pha-
ryngeal cancer, we observed a less pronounced risk
reduction after cessation of alcohol drinking than
for the other head and neck cancer subsites. These
results were essentially unchanged after stratification
by PYs of tobacco smoking and frequency of alcohol
drinking.
The ORs for quitting alcohol drinking did not
change substantially after adjustment for BMI, for
passive smoking or for family history of head and
neck cancer (results not shown). The risk estimates
after cessation of drinking were also not affected by
excluding subjects with chewing or snuff use habits
(results not shown).
When the analysis was stratified separately by age,
sex, education level, race/ethnicity, region, study year
and study sample size, the effect of quitting alcohol
drinking was consistent (results not shown). On the
other hand, we observed differences after stratifica-
tion by study type. Regardless of how many years a
subject had quit drinking, the risk reduction of head
and neck cancer was more pronounced in the seven
hospital-based studies (520 years quitting OR 0.45,
95% CI 0.25–0.81; never OR 0.57, 95% CI 0.39–0.81,
data not shown) than in the four population-based
studies (520 years quitting: OR 0.89, 95% CI
0.54–1.45; never: OR 1.39, 95% CI 0.60–3.18, data
not shown).
Cessation of tobacco smoking
The risk of head and neck cancer decreased among
persons who had stopped tobacco smoking 1–4 years
previously (OR 0.70, 95% CI 0.61–0.81; Table 2). The
reduced risk of head and neck cancer after quitting
smoking for 520 years (OR 0.23, 95% CI 0.18–0.31)
was similar to that of never smokers (OR 0.23, 95% CI
0.16–0.34). Current and former tobacco smokers had
a higher relative risk of laryngeal cancer than oral or
pharyngeal cancer. The inverse relationship was
observed for the risk of all head and neck cancer
subsites for quitting tobacco smoking (P for trend
<0.01). After quitting smoking 520 years, the ORs
were similar to that of never smokers for oral and
pharyngeal cancers, but not for laryngeal cancer.
An inverse association between quitting tobacco
smoking for 520 years and the risk of head and
neck cancer was reported in all studies (Figure 2).
The risk of head and neck cancer after quitting smok-
ing decreased with increasing frequency (Table 3)
and duration of tobacco smoking (data not shown).
We observed an increased risk among former low
frequency smokers who recently stopped smoking
for oral cavity and laryngeal cancer.
After cessation of tobacco smoking, current and
former alcohol drinkers showed a reduced risk
for every head and neck cancer subsite (Table 4).
Among never alcohol drinkers, we observed a risk
reduction due to quitting smoking only for laryngeal
cancer, but not for oral cavity cancer or pharyngeal
cancer. Table 4 was replicated within sub-strata of
frequency of drinking and PY of tobacco smoking.
The results were similar to the overall results.
The reversal of head and neck cancer risk after quit-
ting smoking did not change when subjects with
chewing or snuff use habits were excluded (results
not shown). In addition, exclusion of the Indian cen-
tres of the international multicentre study did not
change our results for the cessation of tobacco smok-
ing or alcohol drinking. Adjustment for BMI at age 30
years or for family history of head and neck cancer
also did not change the inverse association between
smoking cessation and head and neck cancer risk
substantially (data not shown). Strong differences in
the association between smoking cessation and head
and neck cancer were not observed after stratification
by age, sex, race/ethnicity, geographic region, educa-
tion level, study type, study year and study sample
size (results not shown).
Discussion
The results of our pooled analysis showed a beneficial
effect on the risk of all head and neck cancer subsites
after quitting tobacco smoking within as little as 1–4
years. In contrast, we only estimated a benefit on the
risk of head and neck cancer after 20 years of quit-
ting alcohol drinking; the beneficial effect of drinking
cessation was not as substantial as that of smoking
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Figure 2 Cessation of smoking 520 years and head and
neck cancer risk compared with current smoking
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cessation. However, for both cessation of drinking
and cessation of smoking, the risk was reduced to
the level of never users after 20 years of quitting
these habits.
Consistent with the results from previous studies, a
reduced risk of head and neck cancer after drinking
cessation was detected mainly for oral cavity cancer7,9
and laryngeal cancer.16,23 On the other hand, regard-
less of drinking frequency and smoking status, risk
reduction of pharyngeal cancer after stopping drink-
ing was not as strong. These results are also in accor-
dance with published results of the study from
Uruguay,23 and the multicentre study from Italy and
Switzerland.22 Furthermore, individuals needed to
quit drinking for 520 years to show a 40% risk reduc-
tion of head and neck cancer. This may be due to
either a longer time between intake of alcohol and
increase of head and neck cancer risk, or a certain
amount of irreversible damage associated with drink-
ing that are with long-lasting effect. Additionally, it is
possible that the effect of alcohol drinking may act
directly or indirectly in an early phase of the multi-
step process of head and neck cancer develop-
ment.16,22,32 However, such interpretations are
difficult to make based on these data alone, since
underlying mechanisms are complicated and mostly
unknown.33
The risk to ex-smokers was similar to the risk of
never smokers after 20 years for oral cavity and pha-
ryngeal cancer,10,18–21 but not for laryngeal
cancer,15–17 consistent with previous studies. This per-
sistent increased risk for laryngeal cancer compared
with never smokers was also reported for lung
cancer after a long interval of smoking cessation,12
consistent with the notion that laryngeal cancer
shares a closer a etiology with lung cancer than
with oral cavity and pharyngeal cancer.
The inverse association between head and neck
cancer and smoking cessation was stronger than
with drinking cessation. These results are in agree-
ment with most previous studies of drinking and
smoking cessation and the risk of head and neck
cancer.7–10,12,16,23 In addition, our results did not
show a benefit of quitting drinking among former
and never tobacco smokers. A possible explanation
may be that the risk conferred by alcohol drinking
is lower than that conferred by tobacco smoking or
by the joint effect of both, and thus it may be difficult
to detect a risk reduction due to cessation of alcohol
drinking among former and never smokers in epide-
miological studies.
The lack of influence of drinking duration has been
noted in previous studies.18,22 Perhaps there is a cor-
relation of long-term drinking with a less intensive
pattern of alcohol drinking (e.g. occasional drinking,
only with meals). We observed a benefit after quitting
alcohol drinking only for subjects who drank one
drink or more per day. On the other hand, the great
risk reduction of head and neck cancer after quitting
tobacco smoking among short- and long-term smo-
kers, as well as among light and heavy smokers
underscores the importance of preventing head and
neck cancer by encouraging individuals to quit
smoking.
After stratification by study design, we observed
a less pronounced risk reduction of head and
neck cancer after cessation of alcohol drinking in
the population-based studies than in the hospital-
based studies. The statistical power of the popula-
tion-based studies was less than that of the hospi-
tal-based studies, since the majority of our data
were from the latter design. This may explain
our weak association for drinking cessation in the
population-based studies.
Our results should be interpreted carefully, since
this pooled analysis of case–control studies has the
limitation that the exposure assessment could have
been subject to recall bias. Hospitalized cases (regard-
less of study design) and hospitalized controls may
tend to report inaccurately that they have stopped
alcohol drinking before they came to the hospital,
whereas healthy controls from the general population
may be less likely to do so. This may decrease the
proportion of current drinkers among cases who are
hospitalized, which may cause a bias towards the null
of drinking cessation among the population-based
case–control studies. Among the hospital-based stu-
dies, the number of current drinkers may decrease
among cases and controls, and thus the effect of
such a bias is difficult to predict. However, we
observed a lower risk of head and neck cancer after
520 years quitting alcohol drinking among hospital-
based case–control studies compared with population-
based case–control studies.
Given this possibility of recall bias in our analysis of
case–control studies, results from cohort studies
would be important to confirm the effect of drinking
cessation on head and neck cancer risk. Recent cohort
studies showed greater risk of head and neck cancer
due to alcohol drinking than case–control studies.34
Thus, the risk reduction of head and neck cancer
may also be greater after cessation of alcohol drinking
in cohort studies, since the ORs were lower after quit-
ting 520 years if the baseline risk of current alcohol
drinking was higher. However, most cohort studies
only have baseline information on alcohol consump-
tion and do not measure detailed drinking habits
beyond baseline. Thus, it may not be possible to eval-
uate time since quitting drinking over a follow-up
time of 530 years in cohort studies.
The increased risk of head and neck cancer in the
first 2 years of quitting tobacco or alcohol use that we
observed in some sub-groups may be due to the
fact that some cases could have stopped drinking or
smoking because of early symptoms of the disease,
which adds cases to the former users and causes an
underestimation of the reversal in risk after quitting
(exposure misclassification among cases). This seems
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especially true for drinking cessation because in con-
trast to major policies on tobacco, there is no general
public health intervention for quitting drinking
(i.e. higher taxes). Quitting alcohol drinking could
be motivated by other harmful circumstances caused
by alcohol consumption, e.g. social consequences like
dependence or the diagnosis of other diseases. Some
smokers may also not believe that their smoking pat-
tern is unhealthy or may have been unable to stop
prior to having a cancer diagnosis and may stop
smoking only because of early signs and symptoms
of head and neck cancer, which may also increase
the risk of head and neck cancer in the first years
after quitting smoking.
Potential confounders of our results include other
known risk factors of head and neck cancer that
could be associated with quitting drinking or smok-
ing, such as chewing tobacco or snuff use,8,35 low
BMI36 and low vegetable and fruit consumption.
However, adjustment for BMI did not materially
affect the estimates of the beneficial effects of cessa-
tion. The reduced risk of head and neck cancer after
quitting was also not different when subjects with
chewing and snuff use were excluded. High fruit
and vegetable consumption could be associated with
drinking cessation or smoking cessation and could
also reduce the risk of head and neck cancer,
but we believe that this alone could not explain the
strong beneficial effect after quitting smoking or
drinking.
Another possible limitation of our study is the use
of different combinations of studies for different
sub-analyses and the heterogeneity between specific
estimates from the individual studies. This may be
partly due to regional variation of tobacco and alcohol
types and variation of smoking and drinking pattern,
as well as differences in study design. To account
for other unknown sources of heterogeneity in the
analysis, we treated the study effects on a second
level as random variations around a population
mean. In this mixed model, studies were weighted
more equally with increasing heterogeneity by giving
smaller weights to larger studies than in a fixed effect
model.
On the contrary, our pooled analysis has many
strengths. The heterogeneity of the study population
allowed us to evaluate the beneficial effect of cessa-
tion of alcohol drinking and tobacco smoking in
different subgroups, e.g. stratification by geographical
region and sex. Furthermore, the large number of
subjects increased the statistical power for analysing
finer categories, such as cessation of 520 years,
which was especially important for estimating a
beneficial effect after quitting of alcohol drinking
and after quitting of tobacco smoking among never
drinkers.
In summary, cessation of tobacco smoking and
cessation of drinking was associated with a reduction
in the risk of head and neck cancer.
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KEY MESSAGES
 The main risk factors for head and neck cancer are alcohol drinking and tobacco smoking, which
together account for 75% of the disease.
 Our results support that tobacco and alcohol cessation protect against the development of head and
neck cancer.
 Quitting tobacco smoking showed a beneficial effect on the risk of all head and neck cancer subsites
within as little as 1–4 years, whereas cessation of alcohol drinking only provides a benefit after 20
years of quitting.
 For cessation of both smoking and drinking, the risk was reduced to the level of never users after 20
years of quitting these habits.
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